27 Oct 2023
15m
A look at the FDA's Aduhelm approval and the potential for regulatory bias
The Top Line
Open in Podwise to generate AI notes
Sign in to process this episode and unlock summaries, transcripts, highlights and translations.
Shownotes are not generated by Podwise.